The DOI matches its Crossref record; 99 of the 104 references it cites were found in a registry or an index.
Epigenetic gene silencing in cancer: the DNA hypermethylome
Open accessAbstract
Epigenetic gene inactivation in transformed cells involves many 'belts of silencing'. One of the best-known lesions of the malignant cell is the transcriptional repression of tumor-suppressor genes by promoter CpG island hypermethylation. We are in the process of completing the molecular dissection of the entire epigenetic machinery involved in methylation-associated silencing, such as DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylases, histone methyltransferases, histone demethylases and Polycomb proteins. The first indications are also starting to emerge about how the combination of cellular selection and targeted pathways leads to abnormal DNA methylation. One thing is certain already, promoter CpG island hypermethylation of tumor-suppressor genes is a common hallmark of all human cancers. It affects all cellular pathways with a tumor-type specific profile, and in addition to classical tumor-suppressor and DNA repair genes, it includes genes involved in premature aging and microRNAs with growth inhibitory functions. The importance of hypermethylation events is already in evidence at the bedside of cancer patients in the form of cancer detection markers and chemotherapy predictors, and in the approval of epigenetic drugs for the treatment of hematological malignancies. In the very near future, the synergy of candidate gene approaches and large-scale epigenomic technologies, such as methyl-DIP, will yield the complete DNA hypermethylome of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the epigenetic landscape of human malignancies exhibits massive reprogramming in their DNA methylation patterns.”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Self-citationmiR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Cited by
Items 201–300 of 725
Epigenetics-Based Therapeutics for Neurodegenerative Disorders
Xu, Z., Li, H., & Jin, P. (2012) · Current Geriatrics Reports · doi:10.1007/s13670-012-0027-0 · Cited by 50
The Role of Methylation in Breast Cancer Susceptibility and Treatment.
Pouliot, M., Labrie, Y., Diorio, C., & Durocher, F. (2015) · PubMed · Cited by 48
Guo, X., Jing, C., Li, L., Zhang, L., Shi, Y., Wang, J., Liu, J., & Li, C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.026 · Cited by 47
Methylation profiles of hereditary and sporadic ovarian cancer
Bol, G. M., Suijkerbuijk, K. P. M., Bart, J., Vooijs, M., van der Wall, E., & van Diest, P. J. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03642.x · Cited by 49
“Hypermethylation of CpG islands within the promoter region of a tumour suppressor gene (further denoted ‘methylation’) is associated with loss of gene function and thus results in a first and ⁄ or second hit in the Knudson’s two-hit theory.(20,23) Methylation has hardly been studied in hereditary ovarian cancer.”
BackgroundArray-based DNA methylation profiling of primary lymphomas of the central nervous system
Richter, J., Ammerpohl, O., Martín-Subero, J. I., Montesinos‐Rongen, M., Bibikova, M. V., Wickham‐Garcia, E., Wiestler, O. D., Deckert, M., & Siebert, R. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-455 · Cited by 47
“This correlates well with the known phenomenon that CpG islands in promoter regions become methylated during tumorigenesis [31-33].”
BackgroundQadi, S. A., Hassan, M., Sheikh, R. A., Baothman, O. A. S., Zamzami, M. A., Choudhry, H., Al-Malki, A. L., Albukhari, A., & Alhosin, M. (2019) · Epigenetics Insights · doi:10.1177/2516865719839011 · Cited by 47
Ibrahim, A., Alhosin, M., Papin, C., Ouararhni, K., Omran, Z., Zamzami, M. A., Al-Malki, A. L., Choudhry, H., Mély, Y., Hamiche, A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25583 · Cited by 49
Writers, Readers, and Erasers of Epigenetic Marks
Nicholson, T. B., Veland, N., & Chen, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00003-3 · Cited by 58
Scher, M. B., Elbaum, M. B., Mogilevkin, Y., Hilbert, D. W., Mydlo, J. H., Sidi, A. A., Adelson, M. E., Mordechai, E., & Trama, J. P. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.08.015 · Cited by 46
Dysregulation of Cell Death and Its Epigenetic Mechanisms in Systemic Lupus Erythematosus
Wu, H., Fu, S., Zhao, M., Lu, L., & Lu, Q. (2016) · Molecules · doi:10.3390/molecules22010030 · Cited by 53
“Several studies have demonstrated that methyl-CpG-binding domain 4 (MBD4) can be recruited by methylated DNA and thereby leading to the recruitment of histone modifying and chromatin-remodeling complexes to methylated sites [38,39].”
BackgroundDNA Methylation in Osteoarthritis: Current Status and Therapeutic Implications
Miranda‐Duarte, A. (2018) · The Open Rheumatology Journal · doi:10.2174/1874312901812010037 · Cited by 46
“DNA methylation can inhibit gene activity directly because the methylation of promoter CpG islands interferes with the binding of Transcription Factors (TF) to their target sites [14].”
BackgroundPeng, H., Zhang, J., Zhang, P., Chen, L., Tang, L., Yang, X., He, Q., Wen, X., Sun, Y. H., Liu, N., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0997-7 · Cited by 46
Lipid metabolism of cancer stem cells (Review)
Liu, H., Zhang, Z., Song, L., Gao, J., & Liu, Y. (2022) · Oncology Letters · doi:10.3892/ol.2022.13239 · Cited by 52
“Increasing evidence indicates that the silencing of tumor suppressor genes and activation of various cancer genes, which contribute to the formation of CSCs, are closely related to DNA hypermethylation (21).”
BackgroundCurrent Limitations And Future Opportunities For Epigenetic Therapies
Cherblanc, F., Chapman‐Rothe, N., Brown, R. E., & Fuchter, M. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.7 · Cited by 46
Lü, J., Wen, M., Huang, Y., He, X., Wang, Y., Wu, Q., Li, Z., Castellanos‐Martín, A., Abad, M., Cruz, J. J., et al. (2013) · Epigenetics · doi:10.4161/epi.24626 · Cited by 44
“DNA hypermethylation constitutes a major cause of abnormal gene silencing in cancers.(18) However, not all aberrant gene silencing plays functional roles in tumor development, some methylation events might be epigenetic passengers.”
BackgroundKarpiński, P., Myszka, A., Ramsey, D., Misiak, B., Gil, J., Łaczmańska, I., Grzebieniak, Z., Sebzda, T., Śmigiel, R. S., Stembalska, A., et al. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.03.002 · Cited by 44
“Epigenetic inactivation linked to CpG island hypermethylation and gene silencing have been regarded as a common hallmark of human cancer [1].”
BackgroundSohlberg, E., Pfefferle, A., Andersson, S., Baumann, B. C., Hellström‐Lindberg, E., & Malmberg, K. (2015) · Oncotarget · doi:10.18632/oncotarget.6213 · Cited by 47
“Epigenetic modifications are a common hallmark of all human cancers [1] and can include alterations in methylation patterns where methyl groups are added or removed from CpG sites in DNA.”
BackgroundOverview of DNA methylation in adult diffuse gliomas
Aoki, K., & Natsume, A. (2019) · Brain Tumor Pathology · doi:10.1007/s10014-019-00339-w · Cited by 45
Pehlivan, M., Sercan, Z., & Sercan, H. O. (2009) · Leukemia Research · doi:10.1016/j.leukres.2008.11.013 · Cited by 43
Pirola, L., Ciesielski, O., & Balcerczyk, A. (2018) · Cancers · doi:10.3390/cancers10080268 · Cited by 43
Epigenetics in Nucleotide Repeat Expansion Disorders
He, F., & Todd, P. K. (2011) · Seminars in Neurology · doi:10.1055/s-0031-1299786 · Cited by 49
“Alternatively, methylated DNA can directly inhibit interactions between DNA-binding proteins and their targets sequences within promoters.(20) Histones also play a major role in epigenetics.”
BackgroundZhao, Q., Zong, H., Zhu, P., Su, C., Tang, W., Chen, Z., & Jin, S. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00474-x · Cited by 50
“Typically, DNA methyltransferases are highly expressed in various tumor cells, and DNA methylation has been closely associated with depletion of tumor suppressors and differentiation genes [93].”
BackgroundKIM, T.-O., Park, J., Kang, M. J., Lee, S. H., Jee, S. R., Ryu, D. Y., Yang, K., & Yi, J. M. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1317 · Cited by 41
“Promoter CpG island hypermethylation of tumor-suppressor genes has been known as a common hallmark of all human cancer (11).”
He, L., Gao, L., Shi, Z., Li, Y., Zhu, L., Li, S., Zhang, P., Zheng, G., Ren, Q., Li, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119481 · Cited by 40
Epigenetic therapy and chemosensitization in solid malignancy
Ronnekleiv‐Kelly, S. M., Sharma, A. R., & Ahuja, N. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.03.008 · Cited by 43
Townsend, T. A., Parrish, M. C., Engelward, B. P., & Manjanatha, M. G. (2017) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22101 · Cited by 43
“…in DNA methylation status and patterning have been strongly associated with clinical phenotypes and diseases such as cancer [Ordway et al., 2006; Esteller, 2007; Baylin and Jones, 2011; Rakyan et al., 2011; Pogribny and Beland, 2013; McLean et al., 2014] and autoimmune disorders [Hu et al.,…”
Ayurveda: Science of life, genetics, and epigenetics
Sharma, H. M. (2016) · AYU (An International Quarterly Journal of Research in Ayurveda) · doi:10.4103/ayu.ayu_220_16 · Cited by 53
“However, methylation can result in the inappropriate silencing of genes such as tumor suppressor genes.[4,5] Many of these processes are altered in cancer, and there is a great interest in understanding these processes to control the cancer progression.”
BackgroundMcCaughan, F., & Dear, P. H. (2009) · The Journal of Pathology · doi:10.1002/path.2647 · Cited by 45
“The methylation of CpG dinucleotides is a critical epigenomic control mechanism that has been implicated in the pathogenesis of cancer [17] and multigenic non-neoplastic diseases [18], and there is much interest in exploiting specific gene methylation profiles as molecular biomarkers in oncology [19,20].”
BackgroundPromoter CpG Island Methylation Markers in Colorectal Cancer: The Road Ahead
Draht, M. X. G., Riedl, R. G., Niessen, H. E. C., Carvalho, B. G., Meijer, G. A., Herman, J. G., van Engeland, M., Melotte, V., & Smits, K. M. (2012) · Epigenomics · doi:10.2217/epi.12.9 · Cited by 40
Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases.
Niller, H., Bánáti, F., Salamon, D., & Minárovits, J. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-24738-0_3 · Cited by 37
Parfett, C. L. J., & Desaulniers, D. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061179 · Cited by 43
“Epigenetic silencing of tumour suppressor genes (TSG) is considered to be a causative mechanism in human carcinogenesis and these events are often described as early molecular events in the progressive transformation of normal cells into highly malignant derivatives [29,30].”
BackgroundVEZT, a Novel Putative Tumor Suppressor, Suppresses the Growth and Tumorigenicity of Gastric Cancer
Miao, R., Guo, X., Zhi, Q., Shi, Y., Li, L., Mao, X., Zhang, L., & Li, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074409 · Cited by 41
“Epigenetic events, especially promoter methylation, are now widely accepted as the cause of gene silencing [28,29,30,31].”
BackgroundEpigenetic Signaling of Cancer Stem Cells During Inflammation
Liu, Z., Ren, Y., Meng, L., Li, L., Beatson, R., Deng, J., Zhang, T., Liu, J., & Han, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.772211 · Cited by 42
“…signaling can affect the accumulation of cells with stemness and self-renewing capacity, to produce CSCs. DNA hypermethylation of cytosines in CpG dinucleotides in various cancers has been associated with silencing of tumor suppressors and genes regulating differentiation (Esteller, 2007).”
BackgroundMicroRNAs in cancer diagnosis and therapy: from bench to bedside
Hoshino, I., & Matsubara, H. (2012) · Surgery Today · doi:10.1007/s00595-012-0392-5 · Cited by 39
Sarfstein, R., Bruchim, I., Fishman, A., & Werner, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024468 · Cited by 41
“A number of epigenetic drugs have already been approved for the treatment of hematological malignancies [34].”
BackgroundSpitzwieser, M., Entfellner, E., Werner, B., Pulverer, W., Pfeiler, G., Hacker, S., & Cichna‐Markl, M. (2017) · BMC Cancer · doi:10.1186/s12885-017-3244-2 · Cited by 39
“Hypermethylation of CpG dinucleotides (CpGs) in the promoter region of genes frequently results in transcriptional silencing [6] whereas global DNA hypomethylation is linked to chromosomal instability [7].”
BackgroundHussain, S., Singh, N., Salam, I., Bandil, K., Yuvaraj, M., Bhat, M. A., Mir, M. M., Siddiqi, M., Sobti, R., Bharadwaj, M., et al. (2011) · Journal of Receptor and Signal Transduction Research · doi:10.3109/10799893.2011.553836 · Cited by 36
“The highest occurrence of methylation has been observed in gastrointestinal cancers involving both sporadic and inherited types (40,41).”
BackgroundDown-Regulation of FXYD3 Expression in Human Lung Cancers
Okudela, K., Yazawa, T., Ishii, J., Woo, T., Mitsui, H., Bunai, T., Sakaeda, M., Shimoyamada, H., Sato, H., Tajiri, M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080571 · Cited by 39
Epigenetic regulation and therapeutic targets in the tumor microenvironment
Xie, Z., Zhou, Z., Yang, S., Zhang, S., & Shao, B. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00126-2 · Cited by 42
“For example, the hypermethylation of CpG islands in the promoter regions of tumor suppressor genes (TSGs) leads to TSG silencing, eventually result in tumorigenesis [25].”
BackgroundEpigenetic modulators from “The Big Blue”: A treasure to fight against cancer
Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.06.005 · Cited by 42
Pituitary tumours: all silent on the epigenetics front
Dudley, K. J., Revill, K., Clayton, R. N., & Farrell, W. E. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0009 · Cited by 38
“The silencing of TSGs, through or associated with CpG island methylation is recognized as a major mechanism of gene inactivation that frequently coexists with genetic lesions in most cancers studied to date (Esteller 2007).”
BackgroundLinking the Epigenome with Exposure Effects and Susceptibility: The Epigenetic Seed and Soil Model
Bowers, E. C., & McCullough, S. D. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw215 · Cited by 39
EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia
Schäfer, V., Ernst, J., Rinke, J., Winkelmann, N., Beck, J. F., Hochhaus, A., Gruhn, B., & Ernst, T. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2174-8 · Cited by 36
“Hypermethylation of CpG islands close to promoters is an epigenetic modification that frequently results in down-regulation or silencing of genes (Esteller 2007).”
BackgroundMethylation and microRNA-mediated epigenetic regulation of SOCS3
Boosani, C. S., & Agrawal, D. K. (2015) · Molecular Biology Reports · doi:10.1007/s11033-015-3860-3 · Cited by 38
Masuda, K., Banno, K., Yanokura, M., Tsuji, K., Kobayashi, Y., Kisu, I., Ueki, A., Yamagami, W., Nomura, H., Tominaga, E., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.1912 · Cited by 37
“Epigenetic DNA methylation of tumor suppressor genes in the promoter region is generally important in carcinogenesis (6-8).”
Sun, D., Gan, X., Liu, L., Yang, Y., Ding, D., Li, W., Jiang, J., Ding, W., Zhao, L., Hou, G., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04895-6 · Cited by 38
DNMTs inhibitor SGI‑1027 induces apoptosis in Huh7 human hepatocellular carcinoma cells
Sun, N., Zhang, J., Zhang, C., Zhao, B., & Jiao, A. (2018) · Oncology Letters · doi:10.3892/ol.2018.9390 · Cited by 40
Luan, F., Cui, Y., Huang, R., Yang, Z., & Qiao, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-85444-x · Cited by 38
“In cancer, aberrant methylation patterns disrupt gene expression, thereby driving tumorigenesis 56 .”
Khojasteh, A., Khodayari, A., Rahimi, F., Ghaderian, S. M. H., Jafarian, M., Nayebi, A., Akbarzadeh, R., Tabatabayipanah, A., & Jahangirnia, A. (2012) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2012.04.033 · Cited by 35
Epigenomic targets for the treatment of respiratory disease
Bowman, R., Wright, C. M., Davidson, M. R., Francis, S. M. S., Yang, I. A., & Fong, K. M. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902926119 · Cited by 37
“Mutations, amplifications and other genomic alterations can affect the ability of histone acetylases and deacetylases to activate or silence gene expression respectively [18].”
BackgroundOne-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer
Rizzo, A., Napoli, A., Roggiani, F., Tomassetti, A., Bagnoli, M., & Mezzanzanica, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072092 · Cited by 39
Brevet, M., Haren, N., Sevestre, H., Merviel, P., & Ouadid‐Ahidouch, H. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000227810 · Cited by 36
Sahoo, K., Lingasamy, P., Khatun, M., Sudhakaran, S. L., Salumets, A., Sundararajan, V., & Modhukur, V. (2025) · Epigenetics & Chromatin · doi:10.1186/s13072-025-00595-5 · Cited by 54
Brettingham‐Moore, K. H., Taberlay, P. C., & Holloway, A. F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00499 · Cited by 36
Gestational hypoxia and epigenetic programming of brain development disorders
Ma, Q., Xiong, F., & Zhang, L. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.010 · Cited by 35
“DNMT3a and DNMT3b are believed to be responsible for establishing the pattern of methylation during development [23].”
BackgroundPolyamine-based small molecule epigenetic modulators
Sharma, S. K., Hazeldine, S. T., Crowley, M. L., Hanson, A. S., Beattie, R. J., Varghese, S., Senanayake, T., Hirata, A., Hirata, F., Huang, Y., et al. (2011) · MedChemComm · doi:10.1039/c1md00220a · Cited by 37
OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma
Wu, D., Yang, X., Peng, H., Guo, D., Zhao, W., Zhao, C., & Zhou, X. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx073 · Cited by 34
Nutritional genomic approaches to cancer prevention research.
Ross, S. A. (2007) · PubMed · Cited by 34
Šupić, G., Kozomara, R., Zeljić, K., Jović, N., & Magić, Z. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1772-9 · Cited by 34
Roberts, B. K., Collado, G., & Barnes, B. J. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189061 · Cited by 37
Karahan, G., Sayar, N., GOZUM, G., Bozkurt, B., Konu, Ö., & Yuluğ, I. G. (2015) · Oncology Reports · doi:10.3892/or.2015.3940 · Cited by 33
“CpG island methylation at the promoters of tumor suppressor genes is known to be an important factor in the formation and progression of many types of cancer (20).”
BackgroundPromoter hypomethylation of microRNA223 gene is associated with atherosclerotic cerebral infarction
Li, Z., Yu, F., Zhou, X., Zeng, S., Zhan, Q., Yuan, M., Yang, Q., Liu, Y., & Xia, J. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.924 · Cited by 33
The inflammatory effect of epigenetic factors and modifications in type 2 diabetes
Akbari, M., & Hassan‐Zadeh, V. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00663-9 · Cited by 35
“In general, covalent attachment of a methyl group to cytosine residues of DNA is associated with transcriptional silencing, whereas lower levels of DNA methylation are usually considered as a feature of transcriptionally active genes (Esteller 2007; Miranda and Jones 2007).”
BackgroundThe MAL Protein, an Integral Component of Specialized Membranes, in Normal Cells and Cancer
Rubio-Ramos, A., Labat‐de‐Hoz, L., Correas, I., & Alonso, M. A. (2021) · Cells · doi:10.3390/cells10051065 · Cited by 38
The potential of DNA modifications as biomarkers and therapeutic targets in oncology
Jankowska, A. M., Millward, C. L., & Caldwell, C. W. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1084229 · Cited by 35
“In particular, aberrant DNA methylation, both at the individual gene and on a genome-wide scale, has been correlated with the alteration of some tumor suppressor genes [28].”
BackgroundZhao, X., Li, J., Zhuo, J., & Cai, L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.046 · Cited by 33
Allen, B. N., Pezone, A., Porcellini, A., Muller, M. T., & Masternak, M. M. (2017) · Oncotarget · doi:10.18632/oncotarget.16122 · Cited by 32
“Moreover, the addition or removal of post-translational modifications to histones can affect the access of transcriptional machinery to particular genes by opening or closing the chromatin, causing gene activation or repression, respectively [11, 19, 45, 46].”
BackgroundMethodInfluentialEpigenetic Dysregulation in Thyroid Neoplasia
Kondo, T., Asa, S. L., & Ezzat, S. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.12.002 · Cited by 32
Cervical cancer pathogenesis is associated with one-carbon metabolism
Pathak, S., Bhatla, N., & Singh, N. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1362-3 · Cited by 34
“Furthermore, global hypomethylation can be lowered by folic acid supplementation [23], supporting a causal link.”
BackgroundEvison, B. J., Bilardi, R. A., Chiu, F. C. K., Pezzoni, G., Phillips, D. R., & Cutts, S. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp700 · Cited by 32
“Such a strong emphasis on cancerspecific, genome-wide CpG methylation profiling in recent times has seen the term cancer ‘methylome’ become fashionable ( 17 ).”
BackgroundDexheimer, G. M., Alves, J., Reckziegel, L., Lazzaretti, G., & Abujamra, A. L. (2017) · Disease Markers · doi:10.1155/2017/5472893 · Cited by 36
“Aberrant epigenetic mutations have been demonstrated in different leukemia subtypes [48, 49, 55], and the number of identified changes is uprising, including genes involved in a plethora of signaling pathways and cellular processes [56, 57].”
BackgroundXu, Y., Hong, M. H., Kong, D., Deng, J., Zhong, Z., & Liang, J. H. (2022) · BMC Genomics · doi:10.1186/s12864-022-08296-z · Cited by 30
Alvarado, S. G., Wyglinski, J., Suderman, M. J., Andrews, S. A., & Szyf, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074009 · Cited by 32
“Although microRNAs have been demonstrated by several studies to be regulated by DNA methylation [24–27] chromatin modification [28] and transcriptional regulators [29], the possibility that methylated DNA binding proteins could control expression of a group of genes through changing the methylation state of a microRNA…”
Retrotransposons as a major source of epigenetic variations in the mammalian genome
Ekram, M. B., Kang, K., Kim, H., & Kim, J. (2012) · Epigenetics · doi:10.4161/epi.19462 · Cited by 34
Alelú‐Paz, R., Ashour, N., González‐Corpas, A., & Ropero, S. (2012) · Journal of Signal Transduction · doi:10.1155/2012/956958 · Cited by 31
“These genes include most of the well-established tumor suppressor genes that regulate almost all cellular functions, such as cell cycle (p16, p15, RB, and p14), DNA repair (BRCA1, hMLH1, MGMT, and WRN), cell-adherence and invasion (CDH1, CDH13, EXT1, SLIT2, and EMP3), apoptosis (DAPK, TMS1, and SFRP1), carcinogen-meta…”
BackgroundRecent advances in understanding DNA methylation of prostate cancer
Shin, H. J., Hua, J. T., & Li, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1182727 · Cited by 34
“Interest ingly, these CpG hypermethylation profiles are found to be highly tumor-typespecific and may serve as potential biomarkers (15).”
BackgroundSoriano‐Tárraga, C., Jiménez-Conde, J., Steinhauer, E. G., Ois, Á., Rodríguez-Campello, A., Cuadrado‐Godia, E., Fernández‐Cadenas, I., Montaner, J., Lucas, G., Elosúa, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060750 · Cited by 32
“However, DNA methylation also occurs at CpG island shores, in the gene body, and in repetitive elements [1–4].”
BackgroundDemethylating agent 5-aza-2′-deoxycytidine activates HLA-G expression in human leukemia cell lines
Poláková, K., Bandžuchová, E., Kuba, D. M., & Russ, G. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.08.003 · Cited by 30
Integrated Analysis of Mismatch Repair System in Malignant Astrocytomas
Rodríguez‐Hernández, I., Garcı́a, J. L., Santos-Briz, A. J., Hernández‐Laín, A., González-Valero, J. M., Gómez-Moreta, J. A., Toldos, O., Cruz, J. J., Martín‐Vallejo, J., & González‐Sarmiento, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076401 · Cited by 30
“Loss of protein expression could be due to aberrant DNA methylation of cytosine residues in CpG promoter islands that leads to transcriptional silencing of the associated genes [33].”
BackgroundMethylation analysis by DNA immunoprecipitation
Thu, K. L., Pikor, L. A., Kennett, J. Y., Alvarez, C. E., & Lam, W. L. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.22009 · Cited by 32
“…cancer, global DNA hypomethylation and focal hypermethylation of CpG islands associated with key genes are common events, resulting in genomic instability and transcriptional silencing of genes, respectively (Feinberg and Vogelstein, 1983; Jones, 2002; Jones and Baylin, 2002; Esteller, 2005, 2007).”
BackgroundCpG Islands in Cancer: Heads, Tails, and Sides
Ferreira, H. J., & Esteller, M. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7768-0_4 · Cited by 34
Epigenetic Influences in the Obesity/Colorectal Cancer Axis: A Novel Theragnostic Avenue
Ayers, D., Boughanem, H., & Macías‐González, M. (2019) · Journal of Oncology · doi:10.1155/2019/7406078 · Cited by 30
Peng, L. H., Mayhew, C. N., Schnekenburger, M., Knudsen, E. S., & Puga, A. (2008) · Toxicology · doi:10.1016/j.tox.2008.01.002 · Cited by 30
“In tumors and in cancer cell lines, aberrant methylation usually occurs at CpG islands, unmethylated in normal somatic cells and hypermethylated in tumor suppressor gene promoters, representing a major mechanism of gene inactivation in primary human tumors (Fraga et al., 2004; Esteller, 2007).”
BackgroundThe Role of Epigenetics in Neurodegenerative Diseases
Lovrei, L., Maver, A., Zadel, M., & Peterli, B. (2013) · InTech eBooks · doi:10.5772/54744 · Cited by 36
“Indirect transcription inhibition is mediated through promoting activation of methyl-CpG-binding domain (MBD) proteins by methylated DNA, which inhibit transcription [23].”
BackgroundThe EpiTect Methyl qPCR Assay as novel age estimation method in forensic biology
Mawlood, S. K., Dennany, L., Watson, N. D., & Pickard, B. S. (2016) · Forensic Science International · doi:10.1016/j.forsciint.2016.03.047 · Cited by 30
Structural dynamics of nucleosomes at single-molecule resolution
Choy, J. S., & Lee, T.-H. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.06.006 · Cited by 27
Differential expression of GSPT1 GGCn alleles in cancer
Malta-Vacas, J., Ferreira, P., Monteiro, C., & Brito, M. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.08.010 · Cited by 28
“These areas are usually unmethylated in normal somatic cells, which is believed to be a prerequisite for active transcription [33,34].”
BackgroundSakamoto, A., Akiyama, Y., Shimada, S., Zhu, W., Yuasa, Y., & Tanaka, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145630 · Cited by 29
“Abbreviations: BS, bisulfite sequencing; CGI, CpG island; ChIP, chromatin immunoprecipitation; DCKO, double conditional knockout mouse; DGC, diffusetype gastric cancer; GAPDH, glyceraldehyde-3phosphate dehydrogenase; GC, gastric cancer; H3K4me3, histone H3 lysine 4 tri-methylation; H3K9me3, histone H3 lysine 9 tri-met…”
BackgroundStandardization and quality controls for the methylated DNA immunoprecipitation technique
Lisanti, S., von Zglinicki, T., & Mathers, J. C. (2012) · Epigenetics · doi:10.4161/epi.20028 · Cited by 29
“Altered patterns of DNA methylation are associated with altered patterns of gene transcription, which are associated with, and may be causal for some, diseases.(11-14) In addition, there is growing evidence that DNA methylation patterns change during aging.”
Backgroundda Costa, A. N., & Herceg, Z. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.07.005 · Cited by 29
“In fact, CGIs exist in the promoter regions of approximately half of all genes and are usually unmethylated in normal differentiated cells, while CGIs located in intergenic regions are methylated (Esteller, 2007; Taby and Issa, 2010).”
BackgroundEpigenetic perturbations in the pathogenesis of mustard toxicity; hypothesis and preliminary results
Korkmaz, A., Yaren, H., Kunak, Z. I., Uysal, B., Kurt, B., Topal, T., Kenar, L., Uçar, E., & Öter, Ş. (2008) · Interdisciplinary Toxicology · doi:10.2478/v10102-010-0048-5 · Cited by 27
“, epimutations) (Ducasse and Brown, 2006) including epigenetic silencing (Robertson, 2001) of tumor suppressor genes because of hypermethylation (Esteller, 2007).”
BackgroundPhillips, J. M., Burgoon, L. D., & Goodman, J. I. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp108 · Cited by 27
“Epigenetic alterations (e.g., DNA methylation), in addition to mutation, play crucial roles during the multistep/multistage process of tumorigenesis (Esteller, 2007; Loeb and Harris, 2008).”
BackgroundIdentification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancer
O’Leary, K., Shia, A., Cavicchioli, F., Haley, V., Comino, A., Merlano, M. C., Mauri, F. A., Walter, K., Lackner, M. R., Wischnewsky, M. B., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.302 · Cited by 26
“The importance of epigenetic transcriptional silencing as a mechanism of tumour-suppressor gene inactivation is well recognised (Baylin and Herman, 2000; Teodoridis et al., 2004; Esteller, 2007).”
BackgroundAgrelo, R., Arocena-Sutz, M., Setién, F., Aldunate, F., Esteller, M., da Costa, V., & Achenbach, R. E. (2015) · Epigenetics · doi:10.1080/15592294.2015.1027853 · Cited by 29
“In addition, these changes are quite specific(47-50) We hypothesized that if these patients have accelerated aging features, they may have increased WRN promoter methylation, a phenomenon that is well known to silence WRN in different types of cancer.(33,45) This situation was the case in this study at least for na€ıv…”
BackgroundGuo, W., Dong, Z., Shi, Y., Liu, S., Liang, J., Guo, Y., Guo, X., Shen, S., & Wang, G. (2016) · Clinical & Experimental Metastasis · doi:10.1007/s10585-016-9794-x · Cited by 26
“Aberrant hypermethylation of specific CpG islands can lead to the silencing of tumor suppressor genes involved in key cellular pathways [17].”
BackgroundMethylation Profiling in Diffuse Gliomas: Diagnostic Value and Considerations
Wenger, A., & Carén, H. (2022) · Cancers · doi:10.3390/cancers14225679 · Cited by 28
“This mechanism is involved in cancer development, where key tumour-suppressor genes are hypermethylated (silenced) and oncogenes hypomethylated (activated) [38,39].”
BackgroundCharacterizing crosstalk in epigenetic signaling to understand disease physiology
Lempiäinen, J. K., & Garcia, B. A. (2023) · Biochemical Journal · doi:10.1042/bcj20220550 · Cited by 30
Panigrahi, S. K., Vasileva, A., & Wolgemuth, D. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047862 · Cited by 27
“Methylation of DNA is known to be associated with the regulation of tissue-specific gene expression [49,50].”
BackgroundChantepie, S., Vaur, D., Grunau, C., Salaün, V., Briand, M., Parienti, J., Heutte, N., Chèze, S., Roussel, M., Gauduchon, P., et al. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.10.018 · Cited by 26
“Indeed, aberrant methylation more often concerns, not a particular CpG site, but rather groups of several CpGs located in the 5′-untranslated region [26,27].”
BackgroundRichards, H. W., & Medrano, E. E. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00534.x · Cited by 28
“As such, these ‘belts of silencing’ (Esteller, 2007) are considered epigenetic marks for these diseases with prognostic and diagnostic value (Esteller, 2007; Gronbaek et al., 2007; Guil and Esteller, 2008; Klose and Bird, 2006; Laird, 2003, 2005).”
BackgroundInfluential
Metadata
- Authors
- Esteller, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Esteller, Manel
- ORCID
- Esteller, Manel
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-15
- Volume
- 16
- Issue
- R1
- Pages
- R50-R59
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2158207797
- Cited by
- 725
- References
- 104
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 17 · 2023: 34 · 2022: 35 · 2021: 29 · 2020: 17 · 2019: 35 · 2018: 38 · 2017: 44 · 2016: 45 · 2015: 56 · 2014: 36 · 2013: 56 · 2012: 62
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- epigenetic silencing, DNA hypermethylation, methylome, tumor suppressor, DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylase, histone methyltransferase, histone demethylase, Polycomb group proteins, DNA repair genes, microRNA, tumor markers, chemotherapy response prediction, epigenetic drugs, hematologic malignancies
- MeSH terms
- Werner Syndrome Helicase, Aging, Exodeoxyribonucleases, Humans, Neoplasms, RNA, Neoplasm, Werner Syndrome, Genes, Tumor Suppressor, CpG Islands, DNA Methylation, Gene Silencing, MicroRNAs, Epigenesis, Genetic, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.